Apellis Pharmaceuticals shares owned by Bellevue Group
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $49M | 822k | 59.86 |
| 2023-09-30 | $30M | 794k | 38.04 |
| 2023-06-30 | $47M | 519k | 91.10 |
| 2023-03-31 | $73M | 1.1M | 65.96 |
| 2022-12-31 | $57M | 1.1M | 51.71 |
| 2022-09-30 | $69M | 1.0M | 68.30 |
| 2022-06-30 | $55M | 1.2M | 45.21 |
| 2022-03-31 | $56M | 1.1M | 50.81 |
| 2021-12-31 | $31M | 651k | 47.27 |
| 2021-09-30 | $1.6M | 48k | 32.96 |
| 2021-06-30 | $3.0M | 48k | 63.21 |
| 2021-03-31 | $2.1M | 48k | 42.92 |
| 2020-12-31 | $2.7M | 48k | 57.21 |
| 2020-03-31 | $801k | 30k | 26.79 |